Stem Cells and Stem Cell-Derived Factors for the Treatment of Inflammatory Bowel Disease with a Particular Focus on Perianal Fistulizing Disease: A Minireview on Future Perspectives
BioDrugs · 2024-07 · 38 (4) · 527-539
DOI: 10.1007/s40259-024-00661-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioDrugs, online erschienen am 25.06.2024. Verfasst von Amy L Lightner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Surgery, Scripps Clinic, 10667 N Torrey Pines Rd, La Jolla, CA, 92037, USA. alightner@scripps.edu. Hauptthemen laut MEDLINE: Rectal Fistula, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Scripps Research Institute.
Abstract (Originalsprache)
Inflammatory bowel disease remains a difficult disease to effectively treat, especially fistulizing Crohn's disease. Perianal fistulas in the setting of Crohn's disease remain an area of unmet need with significant morbidity in this patient population. Up to one third of Crohn's patients will have perianal fistulizing disease and current medical and surgical interventions are of limited efficacy. Thus, most patients experience significant morbidity, narcotic use, and loss of employment and end up with multiple surgical interventions. Mesenchymal stem cells (MSCs) have shown efficacy in phase 3 clinical trials, but considerable infrastructure challenges make MSCs limited with regard to scalability in clinical practice. Extracellular vesicles, being derived from MSCs and capturing the secretome functionality of MSCs, offer similar physiological utility regarding mechanism, while also providing an off the shelf regenerative medicine product that could be widely used in daily clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Surgery, Scripps Clinic, 10667 N Torrey Pines Rd, La Jolla, CA, 92037, USA. alightner@scripps.edu.
- Molecular Medicine, Scripps Research Institute, La Jolla, USA. alightner@scripps.edu.
- Guy's and St Thomas' Hospital, London, UK.
- King's College London, London, UK.
- University of Manchester, Manchester, UK.
- Vitabolus Inc, San Diego, CA, USA.
Förderung
- Scripps Research Institute
Zitieren
APA
Lightner, A. L., Irving, P. M., Lord, G. M., & Betancourt, A. (2024). Stem Cells and Stem Cell-Derived Factors for the Treatment of Inflammatory Bowel Disease with a Particular Focus on Perianal Fistulizing Disease: A Minireview on Future Perspectives. BioDrugs, 38(4), 527-539. https://doi.org/10.1007/s40259-024-00661-6
Vancouver
Lightner AL, Irving PM, Lord GM, Betancourt A. Stem Cells and Stem Cell-Derived Factors for the Treatment of Inflammatory Bowel Disease with a Particular Focus on Perianal Fistulizing Disease: A Minireview on Future Perspectives. BioDrugs. 2024;38(4):527-539. doi:10.1007/s40259-024-00661-6
BibTeX
@article{Lightner2024,
author = {Lightner, Amy L and Irving, Peter M and Lord, Graham M and Betancourt, Aline},
title = {Stem Cells and Stem Cell-Derived Factors for the Treatment of Inflammatory Bowel Disease with a Particular Focus on Perianal Fistulizing Disease: A Minireview on Future Perspectives},
journal = {BioDrugs},
year = {2024},
volume = {38},
number = {4},
pages = {527--539},
doi = {10.1007/s40259-024-00661-6}
}
EUVIMED